Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Median Technologies

< Previous 1 2 Next >
Median Technologies to Host Two Webcasts and Provide a Company Update on July 20, 2023
From Median Technologies
Via Business Wire
Median Technologies Announces Onboarding of All Academic Sites Involved in the Pivotal Validation Plan for iBiopsy® LCS CADe/CADx SaMD
From Median Technologies
Via Business Wire
Median Technologies Reports Its Business Activity for the First Half of 2023 and Announces the First Step of Its Refinancing Plan
From Median Technologies
Via Business Wire
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 20, 2023
From Median Technologies
Via Business Wire
Median Technologies Reschedules Its Corporate Update Webcasts on May 4, 2023
From Median Technologies
Via Business Wire
Median Technologies to Host Two Webcasts and Provide a Company Update on May 3, 2023
From Median Technologies
Via Business Wire
Median Technologies Reports Full-year 2022 Results and Business Indicators for the First Quarter Of 2023
From Median Technologies
Via Business Wire
Median Technologies to present new and breakthrough results for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device at the European Congress of Radiology, taking place March 1-5 2023 in Vienna, Austria
From Median Technologies
Via Business Wire
Median Technologies Announces Completion of the Q-Submission Phase with the FDA for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
From Median Technologies
Via Business Wire
Median Technologies to Participate in the Cowen’s 43rd Annual Health Care Conference
From Median Technologies
Via Business Wire
Median Technologies to Host Two Webcasts and Provide a Company Update on February 2, 2023
From Median Technologies
Via Business Wire
Median Technologies Announces 2022 Revenue of €23.8 Million, up 16%, and an Order Backlog of €60.8 Million
From Median Technologies
Via Business Wire
Median Technologies: Financial Communications Schedule for the First Half of 2023
From Median Technologies
Via Business Wire
Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations
From Median Technologies
Via Business Wire
Median Technologies Announces Its 2022 Half-year Results and Revenues for the Third Quarter
From Median Technologies
Via Business Wire
Median Technologies Announces Formation of Clinical Advisory Board for iBiopsy® Lung Cancer Screening
From Median Technologies
Via Business Wire
Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 – 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy®
From Median Technologies
Via Business Wire
Median Technologies: Financial Communication Schedule for the Second Half of 2022
From Median Technologies
Via Business Wire
Median Technologies Communicates Its Business Indicators for the Second Quarter of 2022
From Median Technologies
Via Business Wire
Median Technologies to Participate in the 2022 European Congress of Radiology (ECR), July 13 – 17, 2022, Vienna, Austria, with Two Presentations on iBiopsy®
From Median Technologies
Via Business Wire
Median Technologies to host a live webcast and provide a company update on July 12, 2022
From Median Technologies
Via Business Wire
Bryan Garnier & Co Initiates the Coverage of Median Technologies with a “Buy” Recommendation
From Median Technologies
Via Business Wire
Median Technologies to Present an Abstract at the 2022 ASCO Annual Meeting, June 3 – 7, 2022, McCormick Place, Chicago, IL, USA
From Median Technologies
Via Business Wire
Median Technologies Launches Imaging Lab, Spearheading the Integration of iBiopsy® Artificial Intelligence Technologies Into iCRO Imaging Services for Oncology Trials
From Median Technologies
Via Business Wire
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 14, 2022
From Median Technologies
Via Business Wire
Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
From Median Technologies
Via Business Wire
Median Technologies Reports Full-Year 2021 Results and Business Indicators for the First Quarter of 2022
From Median Technologies
Via Business Wire
Median Technologies Brings Forward Its 2021 Annual Results Publication to April 21, 2022
From Median Technologies
Via Business Wire
Median Technologies Announces Design Completion of its iBiopsy® Lung Cancer Screening End-to-end CADe/CADx Software as Medical Device (SaMD) with Outstanding Sensitivity & Specificity Performance
From Median Technologies
Via Business Wire
Median Technologies Announces 2021 Revenue of €20.5 Million, Up 52%, and a Strengthened Cash Position of €39 Million
From Median Technologies
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.